- Home
- OLP vs DCTH Comparison
OLP vs DCTH Comparison
Compare OLP & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLP
- DCTH
- Stock Information
- Founded
- OLP 1982
- DCTH 1988
- Country
- OLP United States
- DCTH United States
- Employees
- OLP N/A
- DCTH N/A
- Industry
- OLP Real Estate Investment Trusts
- DCTH Medical/Dental Instruments
- Sector
- OLP Real Estate
- DCTH Health Care
- Exchange
- OLP Nasdaq
- DCTH Nasdaq
- Market Cap
- OLP 569.9M
- DCTH 518.0M
- IPO Year
- OLP N/A
- DCTH N/A
- Fundamental
- Price
- OLP $26.50
- DCTH $12.57
- Analyst Decision
- OLP Strong Buy
- DCTH Strong Buy
- Analyst Count
- OLP 1
- DCTH 4
- Target Price
- OLP $28.00
- DCTH $22.75
- AVG Volume (30 Days)
- OLP 73.5K
- DCTH 485.6K
- Earning Date
- OLP 03-05-2025
- DCTH 03-06-2025
- Dividend Yield
- OLP 6.86%
- DCTH N/A
- EPS Growth
- OLP 1.45
- DCTH N/A
- EPS
- OLP 1.40
- DCTH N/A
- Revenue
- OLP $90,456,000.00
- DCTH $37,205,000.00
- Revenue This Year
- OLP $4.55
- DCTH $112.81
- Revenue Next Year
- OLP $4.51
- DCTH $61.78
- P/E Ratio
- OLP $18.76
- DCTH N/A
- Revenue Growth
- OLP 0.80
- DCTH 1701.69
- 52 Week Low
- OLP $21.11
- DCTH $4.26
- 52 Week High
- OLP $30.45
- DCTH $16.97
- Technical
- Relative Strength Index (RSI)
- OLP 52.28
- DCTH 39.92
- Support Level
- OLP $25.70
- DCTH $11.11
- Resistance Level
- OLP $26.86
- DCTH $14.61
- Average True Range (ATR)
- OLP 0.61
- DCTH 0.74
- MACD
- OLP -0.02
- DCTH -0.01
- Stochastic Oscillator
- OLP 61.15
- DCTH 27.40
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.